Skip to Content

Sucralfate

In the US, Sucralfate (sucralfate systemic) is a member of the drug class miscellaneous GI agents and is used to treat Duodenal Ulcer, Duodenal Ulcer Prophylaxis, GERD, Hyperphosphatemia of Renal Failure, Stomach Ulcer, Stomatitis and Stress Ulcer Prophylaxis.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A02BX02

CAS registry number (Chemical Abstracts Service)

0054182-58-0

Chemical Formula

C12-H54-Al16-O75-S8

Molecular Weight

974

Therapeutic Categories

Treatment of peptic ulcer

Protectant of gastrointestinal mucosa

Chemical Name

Sucrose hydrogen sulfate basic aluminium salt

Foreign Names

  • Sucralfatum (Latin)
  • Sucralfat (German)
  • Sucralfate (French)
  • Sucralfato (Spanish)

Generic Names

  • Sucralfate (OS: BAN, USAN, DCF)
  • Sucralfato (OS: DCIT)
  • CGA-6J (IS)
  • OS 202 (IS)
  • Sucralfat (PH: Ph. Eur. 8)
  • Sucralfate (PH: BP 2016, Ph. Eur. 8, USP 38)
  • Sucralfatum (PH: Ph. Eur. 8)

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide